NCT01198067 · OUTCOME
Number of Patients Experiencing MTD
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Participants Experiencing Study Medication Maximum Tolerated Dose through Study Completion (Avg. 1 Year)
What was measured
Maximum Tolerated Dose
Groups in this outcome
Cohort 2
2mg Pomolidomide per day per Cycle (Cycle = 28 days)
Cohort 3
1mg Pomolidomide per day per Cycle (Cycle = 28 days)
| Group | Source count |
|---|---|
| Cohort 2 | 3 |
| Cohort 3 | 6 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Cohort 2 | 1 | Not reported | Not reported | Not reported | Not reported |
| Cohort 3 | 5 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 5
- denoms
- counts
- group Id
- OG000
- value
- 3
- group Id
- OG001
- value
- 6
- units
- Participants
- description
- Maximum Tolerated Dose
- groups
- description
- 2mg Pomolidomide per day per Cycle (Cycle = 28 days)
- id
- OG000
- title
- Cohort 2
- description
- 1mg Pomolidomide per day per Cycle (Cycle = 28 days)
- id
- OG001
- title
- Cohort 3
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- Participants Experiencing Study Medication Maximum Tolerated Dose through Study Completion (Avg. 1 Year)
- title
- Number of Patients Experiencing MTD
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle